|
|
Other links at Articles > Internal Medicine |
| 1. |
Recovery: Patients, Families, Communities
|
|
|
Can people with schizophrenia recover? How does symptom reduction differ from skills expansion? Recovery is a process, not an endpoint, so how can clinicians tell if programs are recovery-oriented?
Medscape Psychiatry & Mental Health
|
| 2. |
International Approvals: Isentress, WinRho SDF, Cyanokit
|
|
|
Canada has approved raltegravir tablets (Isentress) and a liquid formulation of a Rho (D) intravenous immune globulin [human] product (WinRho SDF); Europe has approved a hydroxocobalamin kit (Cyanokit). Medscape Medical News
|
|
|